Akıl and colleagues [24] found that NLR values ≥ 2.25 resulted in 73% sensitivity and 74% specificity in identifying PD patients, determining higher predictive power than carcinoembryonic antigen (CEA). This evidence concerns the gene CEACAM5 and Parkinson disease.